Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices.
Excellent balance sheet and good value.
Share Price & News
How has Vincent Medical Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1612 has not had significant price volatility in the past 3 months.
7 Day Return
HK Medical Equipment
1 Year Return
HK Medical Equipment
Return vs Industry: 1612 underperformed the Hong Kong Medical Equipment industry which returned 47.9% over the past year.
Return vs Market: 1612 matched the Hong Kong Market which returned -7.4% over the past year.
Price Volatility Vs. Market
How volatile is Vincent Medical Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall StWho Has Been Buying Vincent Medical Holdings Limited (HKG:1612) Shares?
2 weeks ago | Simply Wall StIs Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
3 weeks ago | Simply Wall StDo You Like Vincent Medical Holdings Limited (HKG:1612) At This P/E Ratio?
Is Vincent Medical Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 1612 (HK$0.65) is trading below our estimate of fair value (HK$0.93)
Significantly Below Fair Value: 1612 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 1612 is good value based on its PE Ratio (13.1x) compared to the Medical Equipment industry average (17.9x).
PE vs Market: 1612 is poor value based on its PE Ratio (13.1x) compared to the Hong Kong market (10.1x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 1612's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 1612 is good value based on its PB Ratio (1.1x) compared to the HK Medical Equipment industry average (2.6x).
How is Vincent Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vincent Medical Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Vincent Medical Holdings is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Vincent Medical Holdings competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Vincent Medical Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1612 has high quality earnings.
Growing Profit Margin: 1612's current net profit margins (6.2%) are higher than last year (2.9%).
Past Earnings Growth Analysis
Earnings Trend: 1612's earnings have declined by -20% per year over the past 5 years.
Accelerating Growth: 1612's earnings growth over the past year (131.5%) exceeds its 5-year average (-20% per year).
Earnings vs Industry: 1612 earnings growth over the past year (131.5%) exceeded the Medical Equipment industry 43.4%.
Return on Equity
High ROE: 1612's Return on Equity (8.2%) is considered low.
Return on Assets
Return on Capital Employed
How is Vincent Medical Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 1612's short term assets (HK$353.3M) exceed its short term liabilities (HK$112.7M).
Long Term Liabilities: 1612's short term assets (HK$353.3M) exceed its long term liabilities (HK$20.9M).
Debt to Equity History and Analysis
Debt Level: 1612's debt to equity ratio (3.7%) is considered satisfactory.
Reducing Debt: 1612's debt to equity ratio has increased from 0.8% to 3.7% over the past 5 years.
Debt Coverage: 1612's debt is well covered by operating cash flow (304.1%).
Interest Coverage: 1612's interest payments on its debt are well covered by EBIT (28.4x coverage).
Inventory Level: 1612 has a high level of physical assets or inventory.
Debt Coverage by Assets: 1612's debt is covered by short term assets (assets are 21.7x debt).
What is Vincent Medical Holdings's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: 1612's dividend (2.46%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.29%).
High Dividend: 1612's dividend (2.46%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.35%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, 1612 has been paying a dividend for less than 10 years.
Growing Dividend: 1612's dividend payments have increased, but the company has only paid a dividend for 3 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (32.2%), 1612's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Ki To (52yo)
Mr. Ki Cheung To serves as Chief Executive Officer and General Manager at Vincent Medical Holdings Limited and has been its Executive Director November 2015. Mr. To is primarily responsible for overseeing ...
CEO Compensation Analysis
Compensation vs Market: Ki's total compensation ($USD198.52K) is about average for companies of similar size in the Hong Kong market ($USD225.23K).
Compensation vs Earnings: Ki's compensation has been consistent with company performance over the past year.
|Chairman & Executive Director||0yrs||HK$1.25m||0.47% HK$2.0m|
|CEO, GM & Executive Director||0yrs||HK$1.55m||2.67% HK$11.0m|
|Assistant GM & Executive Director||3.9yrs||HK$1.26m||0.77% HK$3.2m|
|Engineering Manager & Executive Director||3.9yrs||HK$1.08m||0.77% HK$3.2m|
|Independent Non-Executive Director||3.7yrs||HK$189.00k||no data|
|Independent Non-Executive Director||3.7yrs||HK$189.00k||no data|
|Non-Executive Director||3yrs||HK$189.00k||no data|
|Independent Non-Executive Director||3yrs||HK$189.00k||0.19% HK$780.0k|
Experienced Board: 1612's board of directors are considered experienced (3.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Vincent Medical Holdings Limited's company bio, employee growth, exchange listings and data sources
- Name: Vincent Medical Holdings Limited
- Ticker: 1612
- Exchange: SEHK
- Founded: 1997
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: HK$414.473m
- Shares outstanding: 637.65m
- Website: https://www.vincentmedical.com
Number of Employees
- Vincent Medical Holdings Limited
- Hang Fung Industrial Building
- Flat B2, 7th Floor, Phase 2
- Hung Hom
- Hong Kong
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|1612||SEHK (The Stock Exchange of Hong Kong Ltd.)||Yes||Ordinary Shares||HK||HKD||Jul 2016|
Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing. The company develops medical devices focusing on respiratory products; imaging contrast media power injector disposables; and orthopedic and rehabilitation products for OEM customers. Its respiratory products portfolio includes humidification systems, nCPAP interface systems, respiratory units, electronic air-oxygen blenders, and anesthesia systems. The company’s orthopedic and rehabilitation products comprise various adjustable rehabilitation braces for support and protection, and rehabilitation of various skeletomuscular parts after injury or surgery. It also develops robotic hand training devices. Vincent Medical Holdings Limited sells its products under the Inspired Medical, Hand of Hope, and Hypnus brand names in the People’s Republic of China, the United States, the Netherlands, Australia, Japan, and internationally. The company was founded in 1997 and is headquartered in Hung Hom, Hong Kong. Vincent Medical Holdings Limited is a subsidiary of Vincent Raya International Limited.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/22 13:25|
|End of Day Share Price||2020/02/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.